SoylentNews is people
SoylentNews
AlterNet reports
Embracing a harm reduction and public health perspective, one of the world's most prestigious medical journals has released a signed editorial calling for the legalization, taxation, and regulation of currently illegal drugs.
In an editorial [May 10] entitled Drugs Should Be Legalized, Regulated, and Taxed, Fiona Godlee, editor in chief of the British Medical Journal, notes that under drug prohibition, the global trade "fuels organized crime and human misery", and asks, "Why should it not instead fund public services?"
Citing an opinion piece[1] in the same issue of the BMJ from British members of the Law Enforcement Action Partnership (LEAP, formerly known as Law Enforcement Against Prohibition) Jason Reed and Paul Whitehouse, Godlee notes that in the United Kingdom (as in the United States) "vast sums are spent prosecuting individuals and trying vainly to interrupt the flow of drugs into cities" while that money would be much better "spent on quality control, education, treatment for drug users, and child protection". Under legalization, "revenues could be diverted from criminal gangs into government coffers", she writes.
Godlee notes that the global drug prohibition consensus is fraying around the edges, and points to the example of Portugal, which decriminalized the possession of all drugs in 2001. There, drug use remains in line with levels in other European countries, but the harms associated with drug use under prohibition have decreased dramatically, particularly in terms of fatal drug overdoses and the spread of injection drug-related infectious disease.
[1] Bad link in TFA; corrected in TFS.
Previous: Portugal Cut Drug Addiction Rates in Half by Rejecting Criminalization
(Score: 2) by takyon on Wednesday May 16 2018, @09:05AM
There's one drug that probably wouldn't need a black market if it was available for sale:
https://en.wikipedia.org/wiki/Lysergic_acid_diethylamide#Economics [wikipedia.org]
Theoretically, at those rates, a lone chemist could create a billion doses in 3 years. They would just find it hard to distribute under the current regime. A company could make a truly stupendous amount of LSD with some fancier and automated equipment. Other than initial equipment costs, production costs would be relatively low and storage of unused megadoses of LSD could be done in a compact amount of space (perhaps you could fit 10 billion doses in a single walk-in fridge).
[SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]